Skip to main content
Journal cover image

Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.

Publication ,  Journal Article
Wood, WA; Deal, AM; Abernethy, A; Basch, E; Battaglini, C; Kim, YH; Whitley, J; Shatten, C; Serody, J; Shea, T; Reeve, BB
Published in: Biol Blood Marrow Transplant
March 2013

Patient-reported outcomes (PROs), including symptoms and health-related quality of life (HRQOL), provide a patient-centered description of hematopoietic cell transplantation (HCT)-related toxicity. These data characterize the patient experience after HCT and may have prognostic usefulness for long-term outcomes after HCT. We conducted a study of 32 patients after HCT (10 autologous HCT recipients, 11 full-intensity conditioning allogeneic HCT recipients, and 11 reduced-intensity conditioning allogeneic HCT recipients) to determine the feasibility of weekly electronic PRO collection from HCT until day (D) +100. We used questions from the PRO version of the Common Terminology Criteria for Adverse Events to capture symptoms, and the Patient-Reported Outcomes Measurement Information System Global Health scale to measure physical and mental HRQOL. The vast majority (94%) of patients used the electronic PRO system, with only 6% opting for paper-and-pencil only. The median weekly percentage of participants who completed the surveys was 100% in all cohorts through hospital discharge, and remained 100% for the autologous HCT and reduced-intensity allogeneic HCT cohorts through D+100. Patients were satisfied with the electronic system, giving high marks for readability, comfort, and questionnaire length. Symptom severity varied by absolute level and type of symptom across the 3 cohorts, with the full-intensity allogeneic HCT cohort exhibiting the greatest median overall symptom severity, peaking at D+7. Median physical health HRQOL scores decreased with time in the 3 cohorts, and HRQOL was generally correlated with overall symptom severity. Our results demonstrate the feasibility of frequent electronic PROs in the early post-HCT period. Future studies in larger populations to explore predictive models using frequent PRO data for outcomes, including long-term HRQOL and survival, are warranted.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Biol Blood Marrow Transplant

DOI

EISSN

1523-6536

Publication Date

March 2013

Volume

19

Issue

3

Start / End Page

450 / 459

Location

United States

Related Subject Headings

  • Transplantation, Homologous
  • Transplantation, Autologous
  • Transplantation Conditioning
  • Severity of Illness Index
  • Self Report
  • Quality of Life
  • Myeloablative Agonists
  • Multiple Myeloma
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wood, W. A., Deal, A. M., Abernethy, A., Basch, E., Battaglini, C., Kim, Y. H., … Reeve, B. B. (2013). Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant, 19(3), 450–459. https://doi.org/10.1016/j.bbmt.2012.11.014
Wood, William A., Allison M. Deal, Amy Abernethy, Ethan Basch, Claudio Battaglini, Yoon Hie Kim, Julia Whitley, et al. “Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.Biol Blood Marrow Transplant 19, no. 3 (March 2013): 450–59. https://doi.org/10.1016/j.bbmt.2012.11.014.
Wood WA, Deal AM, Abernethy A, Basch E, Battaglini C, Kim YH, et al. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013 Mar;19(3):450–9.
Wood, William A., et al. “Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.Biol Blood Marrow Transplant, vol. 19, no. 3, Mar. 2013, pp. 450–59. Pubmed, doi:10.1016/j.bbmt.2012.11.014.
Wood WA, Deal AM, Abernethy A, Basch E, Battaglini C, Kim YH, Whitley J, Shatten C, Serody J, Shea T, Reeve BB. Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2013 Mar;19(3):450–459.
Journal cover image

Published In

Biol Blood Marrow Transplant

DOI

EISSN

1523-6536

Publication Date

March 2013

Volume

19

Issue

3

Start / End Page

450 / 459

Location

United States

Related Subject Headings

  • Transplantation, Homologous
  • Transplantation, Autologous
  • Transplantation Conditioning
  • Severity of Illness Index
  • Self Report
  • Quality of Life
  • Myeloablative Agonists
  • Multiple Myeloma
  • Middle Aged
  • Male